Board of Directors
Mr Christopher Fullerton BEc
Chairman
Non-Executive Director Mr Fullerton has extensive experience in investment, management and investment banking and is a qualified chartered accountant. He is the managing director of Mandalay Capital Pty Limited, an investor in listed securities and private equity. Mr Fullerton was non-executive chairman of Cordlife Limited and Health Communication Network Limited, and held non executive directorships with Global Health Limited, The Environmental Group Limited, Standard Chartered Australia Limited, Alliance Properties Limited and Federal Airports Corporation.
Dr Deborah Rathjen BSc (Hons), PhD, MAICD
CEO and Managing Director
Dr Rathjen joined Bionomics in June 2000 from Peptech Limited, where she was general manager of business development and licensing. Dr Rathjen was a co-inventor of Peptech's TNF technology and leader of the company's successful defence of its key TNF patents against a legal challenge by BASF. Dr Rathjen has significant experience in research, business development and licensing and specific expertise in inflammation and cancer. Dr Rathjen is chairman of the AusBiotech Board and a member of the Higher Education Council (SA Government).
Dr Errol De Souza
Non-Executive Director
Dr De Souza is a leader in research and development concerning the central nervous system (CNS). He is the former President and CEO of leading US biotech companies Archemix Corporation and Synaptic Pharmaceutical Corporation. Dr De Souza formerly held senior management positions at Aventis and its predecessor Hoechst Marion Roussel Pharmaceuticals, Inc. Most recently, he was senior vice president and site head of US Drug Innovation and Approval (R&D), at Aventis, where he was responsible for the discovery and development of drug candidates through Phase IIa clinical trials for CNS and inflammatory disorders. Prior to Aventis, he was a co-founder and Chief Scientific Officer of Neurocrine Biosciences. Dr De Souza serves on multiple editorial boards, National Institutes of Health (NIH) Committees and is a director of several public and private companies.
Mr Trevor Tappenden ACA, FAICD
Non-Executive Director
Mr Tappenden was a partner of Ernst & Young between 1982 and 2003, holding a variety of positions including Managing Partner of the Melbourne Office, member of the Board of Partners, head of the Victorian Government Services Group and National Director of the Entrepreneurial Services Division.Mr Tappenden is a director of Public, Private, Government, and not-for-profit organisations, is Chairman of Heide Museum of Modern Art, and a Councillor of RMIT University. He is the Chairman of the Audit and Risk Management Committees of many of those organisations.
